INTRODUCTION 41
The genus Flavivirus (family, Flaviviridae) includes more than 60 enveloped, positive and 42 single-stranded RNA viruses. It was named after the jaundice characteristic of the liver 43 dysfunction caused by the infection with Yellow fever virus (YFV), the funding member of the 44 genus (1). Like a majority of flaviviruses, YFV is an arthropod-borne human pathogen 45 (arbovirus). It was one of the first viruses of humans to be identified, isolated (2), propagated 46 in vitro (3) (4) (5) and studied by genomic sequencing (6, 7) . The YF virion consists in a spherical, 47 83
To date, no antiviral drug is available for YFV treatment, which remains limited to symptomatic 84 and supportive care. Although different molecules have shown in vitro and/or in vivo activity 85 against YFV, none is available for clinical use (6, 27 ). An effective live-attenuated vaccine 86 (strain 17D) was developed in 1936 by M. Theiler. It served as early as 1938 in Brazil (28, 29) 87 and two of its substrains are still widely used for vaccine manufacturing 88 (30), with an annual distribution of 20 to 60 million doses (6) . 89 90 YFV species includes one serotype that groups together 5 African and 2 South-American 91 genotypes (31, 32) . The virus originates in Africa and crossed the Atlantic Ocean to the 92 Americas during the slave trade. Since then, large epidemics have been described in these 93 regions. Human activities ensure further YF dissemination from endemic areas to Europe, 94 North America and the Caribbean (6). Despite vector-control plans and although 500 million 95 doses of vaccine were distributed over the last 50 years (6), YFV is still causing important 96 outbreaks as recently reported in Africa (33) and in South America (34) . This is mainly 97 explained by the efficient maintenance of the virus through its sylvatic cycle from which it can 98 start interhuman transmission cycles. With around 900 million people at risk in endemic areas 99 (26), there is still a need for further understanding YFV molecular mechanisms of replication 100 and virulence in order to identify new therapeutic targets and to develop better 101 countermeasures during outbreaks (34) . 102 103 Several animal models allow to reproduce some aspects of the clinical disease caused by YFV 104 in humans (35) . NHPs (notably sp. Macaca mulatta) reproduce well the features of human YF 105 but the use of such models raises ethical, regulatory and biosafety concerns. Transgenic mice 106 models with defects in the interferon signaling pathway are easier to set up but they poorly 107
reproduce the disease observed in humans. YF infection in hamsters (sp. Mesocricetus 108 Auratus) can cause a viscerotropic disease that affects the liver with symptoms similar to those 109 of the human disease. This model requires the use of adapted strains (15, (35) (36) (37) such as the 110 pathogenic YF hamster-viscerotropic strain Asibi/hamster p7 (Ap7), which was described in 111 2003 (15) . It was derived from the strain Asibi/hamster p0 (Ap0), avirulent in hamsters. After 7 112 passages in hamster, the derived strain Ap7 induced a symptomatic liver infection along with 113 a robust viremia and a high mortality rate. Sequencing of both the parental and daughter strains 114 allowed the identification of 14 nucleotide changes amongst which 7 caused amino-acid 115 modifications. A majority of those mutations fell within the E protein, suggesting an important 116 role of this protein for the observed virulence in hamsters. 117
118
In this work, a subset (10) of the mutations described in YF Ap7 virus was introduced into the 119 genome of the Asibi strain using the Infectious Subgenomic Amplicons (ISA) reverse-genetics 120 method (38). The resulting virus, YF Asibi/hamster p7 Marseille (Ap7M), was inoculated to 121 hamsters and the hamster-lethal infection described for YFV Ap7 strain was reproduced. Each 122 of the non-synonymous mutations included in strain Ap7M was then separately reverted and 123 finally, some of the amino acids responsible for the hamster-virulent phenotype of Ap7M virus 124 were identified by introducing single mutations into the genome of the Asibi strain. 125 #528). All animal experiments were performed in compliance with French national guidelines 140 and in accordance with the European legislation covering the use of animals for scientific 141 purposes (Directive 210/63/EU). 142
144
All mutant strains used in this study were produced using the Infectious Subgenomic 145 Amplicons (ISA) method (38) by which infectious virus can be recovered after transfection into 146 permissive cells of overlapping subgenomic DNA fragments covering the entire genome. 147
148
The Ap7M hamster-adapted strain was created by 149 introducing 10 mutations in the 1 st subgenomic fragment (FI) used for virus production with the 150 ISA method (see Fig 1) . FI region involves nucleotide genome positions 1-3919 that code for 151 proteins C to NS2A. Amongst the 14 changes described in strain Ap7 (9), 6 non-synonymous 152 (NS) and 4 synonymous (S) mutations were introduced into the genome of the YFV strain Asibi 153 (34) (Genbank accession number (AN): AY640589). NS changes were located in the E (Q27H, 154 D28G, D155A, K323R, K331R) and NS2A (T48A) proteins. We could not identify the 155 synonymous mutation described in the NS1 coding region (theoretically in position 3274 on 156 the complete coding sequence (CDS)). In position 4864 (NS3 coding region), our reference 157 strain was similar to strain Ap7 and not to the original Asibi/hamster p0 (Ap0) strain described 158
by McArthur (15) . Hence, aside from three mutations (1 NS, 2 S) strain Ap7M is similar to Ap7 159 strain. Details regarding the genomic composition of strains Ap0, Ap7 and Ap7M are available introduced in the Ap7M sequence, a "reversion" mutant was created by reverting the mutation 164 back to the Asibi strain sequence, leaving other mutations unchanged. 165 166 "Positive" mutant strains were designed by selectively 167
introducing mutations E/Q27H, E/D28G and E/D155A alone or in combination into the 168 sequence of the wild-type strain Asibi. 169 170 "Functional" mutants were designed by replacing 171 either Q27H or D155A changes by a hypothetically functionally equivalent NS mutation. For 172 creating the E/T154A mutant, the D155A change was replaced by a T154A mutation (i.e. by a 173 mutation on the adjacent amino acid residue within the E protein). For creating the E/Q27A 174 and E/Q27N functional mutants, the Q27H change was replaced by Q27A and Q27N 175 mutations, respectively. All strains described in the above section are detailed in Table 1 . 176 177 178 For producing each of the different YFV variants reported in this study, 3 to 4 overlapping DNA 179 fragments were synthesized de novo (Genscript) and amplified by High Fidelity PCR using the 180 Platinum PCR SuperMix High Fidelity kit (Life Technologies) and specific sets of primers. The 181 first and last subgenomic fragments were flanked respectively at 5' and 3' termini by the human 182 cytomegalovirus promoter (pCMV) and the hepatitis delta ribozyme followed by the simian 183 virus 40 polyadenylation signal (HDR/SV40pA). 184
185
In the case of positive mutant strains, High Fidelity PCR amplification and fusion of 186 subfragments FI.1.1 and FI.1.2 allowed the introduction of the required mutations into the 187 subgenomic DNA fragment FI.1bis (see Fig 1) . pCMV and HDR/SV40pA were described by Aubry and colleagues (38) . Table S2 . 214
215
The amount of viral RNA was calculated from standard curves using a synthetic RNA transcript 216 (concentrations of 10 7 , 10 6 , 10 5 and 10 4 copies/μL). Results were normalized using 217 amplification (qRT-PCR) of the housekeeping gene actin (as described by Piorkowski and 218 colleagues (39) ). The standard curves generated for all the YFV-specific assays had coefficient 219 of determination values (R2) >0.98 and amplification efficiencies were between 93% and 100%. Both complete and partial coding nucleotide sequences were determined using next-237 generation sequencing methods: overlapping amplicons spanning either the complete genome 238 sequence or the first part of the genome were produced from the extracted RNA (see 239 corresponding section) using the SuperScript® III One-Step RT-PCR System with 240
Platinum®Taq High Fidelity kit (Invitrogen) and specific primers (detailed in the supplementary 241 Table S3 ). Sequencing was performed using the PGM Ion torrent technology (Thermo Fisher 242 Scientific) following the manufacturer's instructions. Consensus sequence determination was 243 done using CLC genomics workbench software (CLC bio-Qiagen). Substitutions with a 244 frequency higher than 5% were considered for the analysis of intra-population genetic diversity 245 and major/minor variants identification (minor variants: variants frequency >5% and <=75%; 246 major variants: variants frequency >75%). parental Asibi strain is displayed in Table 1. In addition, Table 1 
details the codon changes for 272
all the other mutants used in the current study. The integrity of the genome of both viruses was checked using Next-Generation Sequencing 301 (NGS) methods. No additional mutation was identified in Ap7M strain sequence whereas, for 302
the Asibi/hamster p8 strain, the E/D28G non-synonymous mutation was found to be reverted 303 (i.e., similar to the sequence of the Asibi strain) for both the original Ap8 lyophilisate and the 304 stock produced in BHK21 cells (see Fig 2) . 305
306
Nearly all hamsters inoculated with Ap7M and Ap8 strains developed outward signs of illness 307 such as brittle fur, prostration, dehydration and lethargy. One hamster from the Ap8 infected 308 group did not show any sign of illness, both its liver and blood were tested negative for YFV 309 genome at 8 dpi and it was excluded from analysis. Maximal mortality rates (100%) were 310 observed for both Ap7M and Ap8 strains (see Fig 3) , similar to previous observations by 311
McArthur et al. for Ap7 strain infection in hamsters (15) . Clinical signs of the disease appeared 312 as early as 4 dpi and all animals died within two days after onset of the symptoms. No weight 313 loss was observed at 2 dpi (means of %IW of 99% and 102% for Ap7M and Ap8 virus, 314 respectively). In contrast, severe weight loss was recorded at 5 dpi in both groups (means of 315 %IW of 69% and 66%, respectively). 316 317 All livers were found to be YFV-positive by qRT-PCR in both infected groups. Viral RNA loads 318 in the liver samples ranged between 1.10 8 and 4.10 9 RNA copies per gram of liver. There was 319 no significant difference observed between the viral yields at 2 and 5 dpi and endpoint viral 320 loads in the Ap7M-infected group. In the Ap8 group, a significant increase was observed 321 between day 5 pi and endpoint viral loads (Wilcoxon rank-sum test (WRST), p=0.029). For 322 both groups, viral loads' evolution in the liver suggests a peak period between 3 and 4 dpi. 323 324 Next Generation Sequencing (NGS) was performed from liver homogenates recovered from 325
Ap7M-infected hamsters. Sequencing of the liver samples was achieved on the structural 326 proteins' coding region (ORF nucleotide positions 1-3879) and performed for the five hamsters 327 used for mortality rate evaluation. For intra-population genetic diversity analysis, a variant was 328 regarded as major when the corresponding nucleotide proportion (CNP) was over 75%. All 329 sequencing results are shown in Table 2 . In the case of the Ap7M strain, no change in the viral 330 sequence was detected after propagation in hamsters. The in vivo phenotype observed for this 331 strain in hamsters is thus attributable to the 10 mutations introduced into the Asibi strain 332 genome. In total, 6 deletion mutants were designed by selectively deleting (i.e. reverting 340
to Asibi strain sequence) each of the non-synonymous mutations present in the E (5 mutations) 341 and NS2A (1 mutation) genes of Ap7M. Details regarding the sequences of the reversion 342 Table 1 . Each of the deletion mutants was produced using 4 subgenomic 345 amplicons that were amplified and transfected in BHK21 cells (see Fig 1) . After transfection, 346 all viruses were passaged, stored, sequenced and titrated as described for Ap7M virus. 347 348 Infection, clinical and virology follow-up as well as NGS were achieved as 349 described for strain Ap7M. Nine hamsters were inoculated with mutant strain E/G28D and 2 350 hamsters were used for virology investigations at 2 and 5 dpi. All details regarding the in vitro 351
and in vivo phenotypes of reversion mutant strains are available in only the desired reversion. The E/A155D sequence was strictly identical to the sequence 356 designed in silico, but the E/H27Q sequence had six extra mutations (2 non-synonymous and 357 4 synonymous), although all of them were associated with minor variants (CNPs between 60 358 and 65%) ( Table 2) . 359
360
No death was observed in groups infected with E/H27Q and E/A155D reversion mutants. This 361 dramatic change in mortality rate came along with higher means of %IW at 5 dpi (77% for both 362 groups, respectively) and lower viral loads' means at 2 dpi (6.10 6 and 4.10 7 for E/H27Q and 363 E/A155D-infected groups, respectively) and at endpoint (7.10 7 and 2.10 7 for E/H27Q and 364 E/A155D-infected groups, respectively, with WRST p=0.007937 for both viruses). Analysis of 365 the partial sequences obtained from liver homogenates of E/A155D-infected hamsters showed 366 no additional change to the viral sequence. Besides, mutations associated to minor variants in 367 E/H27Q viral stock sequence were found to be reverted when sequencing the liver samples. 368
An additional non-synonymous change (I3V) was identified in the NS2A coding region of the 369 sequences from two liver samples (see Table 2 ) but was associated to a minor variant in both 370 cases (CNPs of 59,2% and 61,8%, respectively). Hence, the change in the in vivo phenotype 371 observed for reversion mutants E/H27Q and E/A155D is undoubtedly imputable to the 372 reversion of mutations E/Q27H and E/D155A, respectively. 373
374
In the case of mutant E/G28D, the complete coding sequence obtained from the viral stock 375 included only the desired reversion. In the E/G28D-infected group, the mortality rate was 376 decreased (60%) and a slight reduction of the viral load was observed at 2 dpi (mean: 2.10 7 ). 377
However, means of %IW at days 2 (101%) and 5 pi (71%) and mean viral loads at 5 dpi (mean: 378 2.10 9 ) and at endpoint (6.10 8 ) were similar to those observed in the Ap7M-infected group. The 379 sequences obtained from infected hamster livers homogenates were similar to those of the 380 inoculum (viral stock). In consequence, the E/D28G mutation reversion can account for the 381 mild changes in the in vivo phenotype that were observed. 382
383
In the case of E/R323K, E/R331K and 384 NS2A/A48T mutant strains, mutations associated to major variants were identified in complete 385 sequences from the viral stocks. One synonymous mutation was identified in the NS1 coding 386 region of NS2A/A48T. Six mutations were detected in the sequence of E/R323K mutant strain 387 (3 NS and 3 S). Amongst the 3 NS changes, only one was located in the E coding region 388 (D37G). In the sequence from mutant E/R331K viral stock, two mutations were observed (1 389 NS and 1 S) including a NS change located in the prM region (A133V). Only the synonymous 390 change was associated to a major variant. 391
In groups infected with mutants E/R323K, E/R331K and NS2A/A48T both clinical and 392 virological evolutions were similar to those observed in the model infection (Ap7M strain). 393
Clinical signs of illness appeared between 4 and 5 dpi, shortly followed by death with mortality 394 rates between 80 and 100%. As observed for Ap7M-infected group, means of %IW were close 395 to 100% at 2 dpi (94, 100 and 100% for E/R323K, E/R331K and NS2A/A48T-infected groups, 396 respectively) and decreased dramatically at day 5 pi (69, 72 and 69%, respectively). Mean 397 viral loads ranged from 5.10 7 to 1.10 9 at 2 dpi, with a 1-log increase between day 2 and 5 pi, 398 and peaked around 3 dpi. 399
400
In the case of strain NS2A/A48T, the undesired NS1 synonymous mutation was found again 401 in the partial sequences from liver samples. Three additional changes (2 NS and 1 S) were 402 detected in the E coding region (T66A, M198L) from one of the liver homogenates but none of 403 them was associated to a major variant (CNPs between 51% and 52%). The preservation of 404 an in vivo phenotype similar to that of Ap7M and the absence of NS mutations associated to 405 major variants suggest a subordinate role of mutation NS2A/T48A in Ap7M strain virulence. 406
407
Regarding strain E/R331K, both undesired mutations detected in the viral stock sequence were 408 also identified as major variants in the partial sequences obtained from hamster livers (CNPs 409 >80%). For strain E/R323K, the envelope non-synonymous change D37G was identified as a 410 major variant (CNPs >90%) in all partial sequences from hamster livers. Although for both 411 strains, the in vivo phenotype was close to that of Ap7M, owing to the presence of additional 412 NS mutations in the prM and E genes of E/R323K and E/R331K strain, respectively, no 413 definitive conclusion can be drawn regarding the phenotypic impact of E/K323R and E/K331R 414 mutations in vivo. 415 416 417 418 A clear phenotypic impact was evidenced for the reversion of mutations E/Q27H, 419 E/D28G and E/D155A. Based on these results, 4 "positive" mutants were designed by 420 selectively introducing one or more of these mutations into the sequence of YFV strain Asibi: 421
Asibi E/Q27H, Asibi E/D155A, Asibi E/Q27H-D155A and Asibi E/Q27H-D28G-D155A. These 422 mutants are described in Table 1 . As for the reversion mutants, all Asibi "positive" mutants 423 were produced by amplifying and transfecting 4 subgenomic amplicons in BHK21 cells. 424
Additional steps of amplification and fusion were performed to introduce the required mutations 425 into the first DNA fragment of YFV Asibi strain FI.1bis (see Fig 1) . All viruses were 426 subsequently passed, stored, sequenced and titrated, as described above. 427 428 Infection, clinical and virology follow-up as well as NGS were achieved as 429 described for strain Ap7M. Groups were limited to 5 hamsters that were used for mortality rate 430 evaluation and virus detection in the liver either at 8 dpi or post-mortem. As controls to this 431 experiment, two groups of 5 hamsters were infected with YFV strains Ap7M and Asibi, 432 respectively. The in vitro and in vivo phenotypes of all positive mutant strains are described in 433 Table 3 . 434
435
Results obtained with the Ap7M-infected group were comparable to those previously observed. 436
The mortality rate was maximal (100%), with clinical signs of illness appearing as early as 4 437 dpi and a severe weight loss observed between 2 and 5 dpi (mean of %IW: 101 and 73%, 438 respectively). Viral loads were slightly inferior to those previously reported in Ap7M-infected 439 hamsters (mean: 2.10 7 ). The unusually long disease of one of the hamsters in Ap7M-infected 440 group led to the extension of the experiment to 9 dpi. 441
No death and nearly no disease was observed in the Asibi-infected group. The clinical signs 442 of illness were limited to a mild loss of weight at 5 dpi (mean of %IW: 93%) and endpoint viral 443 loads were 2 logs lower than those observed in the model infection (mean: 2.10 5 , WRST 444 p=0.007937). 445 446 All groups infected with Asibi "positive" mutant strains showed signs of severe viscerotropic 447 disease. 448
449
Two non-synonymous changes were detected in the 450 sequence from the viral stock of mutant strain Asibi E/D155A in the C (V80A) and NS2A 451 (V158A) proteins and were both identified as major variants (CNPs of 79,7 and 81,3%, 452 respectively). A high mortality rate (60%) was observed in E/D155A-infected group and both 453 clinical and virological evolutions were similar to those observed in hamsters infected with 454
Ap7M. Mean %IW decreased from 98% at 2 dpi to 75% at 5 dpi and mean endpoint viral loads 455 were close to those observed in the Ap7M infection (7.10 6 ). All hamsters showed dehydration 456 signs and brittle fur, and prostration was recorded for most of them (60%, data not shown). 457
When sequencing liver samples from infected hamsters, the C protein NS mutation was still 458 present in all samples. Since no additional mutation was observed in the E protein gene, it is 459 probable that the phenotypic change observed is attributable to the E/D155A mutation. 460
461
The complete coding sequence obtained from the 462 supernatant of cells infected with the Asibi E/Q27H strain was similar to the in silico designed 463 sequence. A moderate mortality rate (20%) was recorded amongst E/Q27H-infected hamsters. 464 Important weight loss was observed between 2 dpi (mean of %IW: 98%) and 5 dpi (mean of 465 %IW: 74%) but the endpoint viral loads mean was significantly lower than that of the Ap7M 466 infection (4.10 6 ). Whilst all hamsters showed dehydration signs and brittle fur, prostration was 467 observed in only one of them (data not shown). All non-synonymous mutations identified in the 468 4 partial sequences obtained from infected hamster liver homogenates (1 partial sequence 469 could not be obtained) corresponded to minor variants (CNPs between 69% and 71%). 470
Altogether, the moderate phenotypic change observed in positive mutant strain E/Q27H, can 471 be attributed to mutation E/Q27H. 472
In the case of strain Asibi E/Q27H-D155A, 6 474 mutations were detected in the complete coding sequence of the virus, including 2 NS changes 475 located in proteins prM (V133M) and NS5 (T789A), all associated with minor variants (CNPs 476 between 68 and 74%). In E/Q27H-D155A infected groups, the mortality was moderate (20%), 477 accompanied by an important weight loss between 2 and 5 dpi (from a mean of %IW of 98% 478 to 72%), endpoint viral loads close to that observed in the model infection (mean: 7.10 6 ) and 479 additional clinical signs of illness limited to dehydration signs and brittle fur (data not shown). 480
The NS prM change V133M, was found in the partial sequences from 4 of the infected 481 hamsters and corresponded to major variants (CNPs of 87.7 and 91.1%). It was found to be 482 reverted in the last one. This experimental set globally confirms that mutations at positions 483 E/Q27H and E/D155A modulate virulence in hamsters. 484
485
The sequence of Asibi E/Q27H-D28G-D155A 486 mutant showed 6 additional mutations (2 NS and 4 S), all associated to major variants 487 (CNPs>95%), notably affecting prM (V142A) and E (M404V) proteins. A high mortality rate 488 (60%), important weight loss between 2 and 5 dpi (from a mean of %IW of 99% to 73%) and 489 endpoint viral loads close to that observed in the model infection (mean: 9.10 6 ) were observed. 490
Dehydration signs, brittle fur and prostration were reported in nearly all cases (80%, data not 491 shown). The envelope M404V change, was detected and associated to major variants in the 492 majority of the sequences (4/5) but was found to be reverted in the last one. Interestingly, two 493 additional mutations were identified in this sequence. They both corresponded to major 494 variants (CNPs of 80.3 and 80.9%) and included a NS change in the NS2A protein (T105A). 495
The corresponding hamster died of viral infection so no specific phenotype could be attributed 496 to those mutations. Those results globally confirm that variants at positions E/Q27H, E/D28G 497 and E/D155A can strongly modify virulence in hamsters. 498 499 500 501 502
The amino acid substitutions Q27H and D155A were identified as sufficient to induce a 503 pathogenic phenotype in hamsters for the Asibi strain (see above). In the structure of the YFV 504 E protein (Asibi strain, pdb accession code 6EPK), both residues Q27 and D155 are in domain 505 I and their side chains are involved in polar interactions that could affect the conformation of 506 the protein. Residues Q27 and D28 are at a β-turn connecting strand B0 and C0 of domain I. 507
The Q27 side chain accepts a hydrogen bond from the main chain amide of G278 at the end 508 of the kl hairpin of domain II. This interaction therefore imposes constraints in the conformation 509 of the polypeptide chain in the hinge area between domains I and II, which has been reported 510 earlier to affect flavivirus virulence (41). Modeling a Histidine residue at this position resulted 511 in conformers that could not make the same interactions as Q27, because the imidazole ring 512 in the side chain projected out differently. Mutation of the Q27 residue to an asparagine (which 513 would not be long enough to make the same interactions as Q27) or to an alanine should affect 514 the interactions observed between Q27 and the main chain in a way analogous to that 515 observed with H27 residue. 516 517 D155 is in the "150 loop" of domain I, a variable segment across the flavivirus E proteins which 518 is exposed at the surface of the virion; the E proteins from many flaviviruses carry a 519 glycosylation site in this loop (42) (43) (44) (45) . Although there is no N-linked glycan attached to YFV E 520 protein, the structure shows that D155 is in a short alpha helix, and its side chain makes a 521 hydrogen bond with that of the preceding residue, T154, which is likely to stabilize the 522 conformation of the helix. If the disruption of this interaction is important for the virulent 523 phenotype of Ap7M, mutation of T154 residue to alanine would also disrupt this interaction, 524
with an effect similar to that of the D155A mutation and thus, induce virulence in hamsters. To test the potential role of the interactions observed by G27 and D154 in the 530 Asibi strain, the Q27H and D155A, "functional" mutants were designed by substituting those 531 two mutations with the potentially functionally similar mutations discussed above. 532
533
In the E/Q27A and E/Q27N functional mutants, the E/Q27H histidine (in the Ap7M strain) was 534 replaced by an alanine or an asparagine residue, respectively. In the E/T154A functional 535 mutant, the E/D155A alanine (in Ap7M strain) was reverted to the original aspartic acid (in 536
Asibi strain) whilst the amino acid in position E/T154A was changed from a threonine to an 537 alanine (see Table 1 ). 538 539 All functional mutants were produced using 4 subgenomic amplicons that were amplified from 540 the corresponding plasmids and transfected in BHK21 cells (see Fig 1) . Following transfection, 541 the viruses were passaged, stored, sequenced and titrated similarly to the other viruses. 542 543 Infection, clinical and virological follow-up as well as NGS were achieved as 544 described for the positive mutant strains. As a control for this experiment, a group of 5 hamsters 545 was infected with YFV strain Ap7M. Next-generation sequencing on the liver homogenates 546 recovered from infected hamsters was only performed for Ap7M E/T154A virus (results shown 547 in Table 3 ). All the details regarding means of %IW, viral loads' means and mortality rates are 548 available in Fig 3.  549   550 All hamsters from the Ap7M-infected group were affected by a severe viscerotropic disease, 551
with the first outward signs of illness appearing from 4 dpi. Death was observed as soon as 5 552 dpi and until 8 dpi, a delay accompanied by a mortality rate slightly lower than that previously 553 observed (80%). Although mean of %IW at 5 dpi was higher than in the other experiments 554 (78%), severe weight loss was subsequently observed at 6, 7 and 8 dpi (mean of %IW of 68, 555 61 and 55%, respectively) and high endpoint viral loads (mean: 3.10 10 ) were recorded. 556 557 One additional NS mutation was detected in the sequence of strain 558
Ap7M E/T154A in the region coding for the NS2A protein (V19A) and was associated to a 559 major variant (CNPs >95%). The hamsters infected with E/T154A mutant strain nearly all 560 showed signs of a severe viscerotropic disease (4 out of 5 individuals). Although the mortality 561 rate was lower (40%), both clinical and virological evolutions were close to those observed in 562 the group infected with strain Ap7M. Mean of %IW fell from 102% at 2 dpi to 78% at 5 dpi and 563 decreased until 64% at 8 dpi. Viral loads were high and varied between 5.10 8 and 3.10 10 , with 564 no significant difference compared to Ap7M infection. The NS change V19A was identified as 565 associated to a major variant in the partial sequences from all liver homogenates with no 566 additional change. Since no additional mutation was observed in the E gene, it is very likely 567 that the restoration of Ap7M virulence in hamsters is attributable to the E/T154A mutation. 568
569
The sequence of mutant Ap7M E/Q27N included 3 additional 570 mutations including 2 NS changes located in the E (K200N) and in the NS1 (S192G) coding 571 regions. As the residue 202 in E protein is a serine, the K200N change introduces a new N-572 glycosylation site within the E protein. Only the NS1 mutation corresponded to a major variant. 573
Although no death was observed in the group infected with E/Q27N mutant, all hamsters 574 showed signs of illness, including an important loss of weight (mean of %IW of 80% at 5 dpi 575 and between 74 and 75% from 6 dpi to 8 dpi). However, endpoint viral loads were significantly 576 reduced compared to that observed with strain Ap7M (mean: 3.10 5 , WRST p=0.007937). 577
Although a NS mutation was identified in the NS1 gene of mutant E/Q27N, there are grounds 578 to believe that mutation E/Q27N did not allow the recovery of the in vivo phenotype of Ap7M 579 and therefore, did not provide a functional equivalent to the E/Q27H mutation observed in 580
Ap7M strain. 581
582
In the sequence of the functional mutant strain Ap7M E/Q27A, 6 583 extra mutations were identified (3 NS and 2 S). NS changes affected E (V281A), NS1 (F104L) 584 and NS4B (L19S) proteins and were all associated to major variants (CNPs>95%). Hamsters 585 from the E/Q27A-infected group showed no clinical signs of disease and no mortality nor loss 586 of weight was recorded in this group (minimum mean of %IW: 99%, reached at 5 dpi). In 587 addition, endpoint viral loads were low, i.e. comprised between 0 and 1.10 6 (WRST 588 p=0.01116). The observed in vivo phenotype cannot be reliably associated to mutation E/Q27A 589 since 3 additional NS mutations were identified in the mutant protein sequence, notably in the 590 envelope gene (V281A). 591
DISCUSSION 592
This study started with providing a proof of concept that the recently described ISA (Infectious 593 Subgenomic Amplicons) reverse genetics method (38) could be used to produce genetically 594 engineered flaviviruses with specific phenotypic properties. Here, we first produced an 595 equivalent to the hamster-virulent strain Yellow Fever Ap7 (15) by simply introducing a set of 596 10 mutations into a single subgenomic amplicon derived from the sequence of the Asibi strain. 597
When inoculated to young female hamsters, the resulting strain, YF Ap7M, induced a lethal 598 viscerotropic disease similar to that described for YF Ap7 virus in terms of clinical signs of 599 illness, weight evolution, viral loads in the liver and lethality (100%). We further exploited the 600 ISA methodology by producing a set of mutant strains derived from either Ap7M or Asibi 601 viruses and allowing to investigate for each of the non-synonymous mutations differentiating 602
Ap7M from Asibi (alone or combined), the impact on the in vivo phenotype of the virus. The 603 approach was classical, but it is noticeable that the absence of requirement for cloning a 604 complete modified genome allowed the simple and convenient production of multiple mutants 605 from subgenomic synthetic fragments in days, with a one hundred percent success in virus 606 recovery. Then, the combination of the ISA reverse-genetics approach and next-generation 607 sequencing proved to be critical to correctly associate the mutation(s) introduced to the in vivo 608 phenotype of the mutants. Obviously, a process excluding exhaustive genetic data analysis 609 would have led, in some cases, to inaccurate conclusions. Indeed, we detected undesired non-610 synonymous mutations, notably in the E protein coding region of several sequences retrieved 611 from the hamster liver samples. These mutations polluted the interpretation however, our 612 results indicate that some of the changes introduced within the E protein sequence have a 613 significant impact on the virulence phenotype of the mutant strains, suggesting that the 614 corresponding amino acid residues are involved in interactions that are relevant for the 615 pathogenic features of yellow fever virus. 616
617
Two of the E protein variant residues turned out to be key components of the virulence 618 mechanism in hamsters. The reversion in Ap7M of either E/Q27H or E/D155A mutations to the 619 original Asibi residue, led to an important reduction of virulence: lethality was abolished, viral 620 loads were reduced, and clinical signs of illness were, to a variable extent, alleviated. In 621 addition, the introduction of the single D155A Ap7M mutation into the E protein of the YF strain 622
Asibi, was sufficient to drastically modify its in vivo phenotype in hamsters towards both a 623 greater replication efficiency (i.e. with higher viral loads) and virulence (i.e. with increased signs 624 of illness and lethality). The impact of other Ap7M mutations could not be fully determined 625 because production in cell cultures was associated with the appearance of undesired non-626 synonymous mutations. 627
628
The structure of YFV E protein (Asibi strain, PDB 6EPK) shows that the side chains of residues 629 Q27 and D155 are involved in polar interactions that could impact the overall conformation of 630 the protein.
Using functional mutants, we tested the implication in YF Ap7M virulent phenotype 631 of both modifications of the interactions between Q27 and the main chain (at position E278) 632 and between T154 and D155 residues. We replaced H27 residue (in Ap7M) with the residues 633 A27 and N27, which would not be able to make the same interactions as Q27, but failed to 634 restore the Ap7M in vivo phenotype. In contrast, replacement of D155A with a T154A change 635 within the sequence of the Ap7M sequence allowed the recovery of a hamster-virulent 636 phenotype. This result provides a structural basis for the relationship between mutation 637 E/D155A and the virulence in hamsters observed with the Ap7M virus. 638
639
The identification of residues in the yellow fever virus E protein carrying the virulence 640 phenotype in hamsters is of utmost interest for the in vivo testing of antiviral molecules against 641 YFV. It implies that the efficacy and the mechanism of action of antivirals targeting the non-642 structural proteins of the virus can be tested in a reproducible lethal hamster model (after 643 providing the relevant mutations in the E gene), using genetic engineering of the target gene. 644
Our study shows that this is possible using the genetic backbone of the Asibi strain but it 645 remains to be established whether the determinants of virulence in this evolutionary lineage 646 can be used to modulate virulence in other genotypes. An alignment of 169 YF envelope 647 sequences indicates that E/Q27H and E/D155A mutations cannot be found in any other YF 648 sequences with the exception of the in vitro adapted Asibi-LP-CDC HeLa p6 strain (15, 46) , 649 the virulence of which in hamsters has not been reported. Thus, although obtaining a hamster-650 virulent phenotype should not be taken for granted, there is a potential for rapidly modifying 651 other YF strains in the prospect of in vivo studies. Of note, other yellow fever virus strains 652 (Jimenez p0 and p10) have been reported to be virulent in hamsters (36). Unfortunately, the 653 only available sequence (Jimenez p0, GenBank AN: AY540480) is partial and does not include 654 the region of interest in the E gene. Further analysis of Jimenez p0 and p10 sequences should 655 prove valuable to determine if these strains share some of the determinants of yellow fever 656 virus virulence in hamsters described in our study. 657
658
Finally, the hamster-virulent strains described in this study are a tangible example of how a 659 few mutations in the genome of flaviviruses can impact replicative fitness and virulence in an 660 unusual host. Rodents have never been reported as hosts for YFV in nature and primary 661 isolates do not grow well in hamsters (35). As described above, the Asibi strain causes only a 662 limited and inapparent infection in hamsters. This work brings reasonable grounds to believe 663 that, if flaviviruses were led by a conjunction of environmental and anthropic factors to cross 664 species barrier, a very limited number of mutations could be enough for the virus to acquire an 665 increased replicative fitness but also a virulent phenotype. 
Asibi Ap7M
Reversion mutant Positive mutant Functional mutant
All viral strains produced and used in this study are detailed above. *The
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Amino Acid (AA) position is given with reference to the beginning of mature protein sequence (ie. AA position 107 in prM, written prM 107, corresponds to AA position 228 within 793 the precursor polyprotein). A detailed map of protein positions within the YFV polyprotein sequence is provided in the supplementary 
801
For each reversion mutant, the changes found either in the complete coding sequence from the viral stock or in partial sequences from 33 infected hamster liver homogenates are detailed above. For mutations identified in more than one sequence from hamster liver, 1 st and 2 nd variants proportions are given as 803 means. Expected sequence refers to that of plasmids that served as templates for subgenomic fragment amplification while producing viruses thanks to the ISA method.
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For each reversion mutant, the changes found either in the complete coding sequence from the viral 807 stock or in partial sequences from infected hamster liver homogenates are detailed above. For mutations identified in more than one sequence from hamster liver, 1 st and 2 nd 35 mutation introduction) that served for subgenomic fragment amplification. For Asibi E/Q27H-D155A and Asibi E/Q27H-D28G-D155A mutants, some mutations were found to 810 be reverted in one out of the five hamsters as indicated by the star (*). In this case, the 1 st and 2 nd variants proportions were not included for means' calculation
